Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Isenberg

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Arthritis and Rheumatism|June 28, 2006
Usefulness of the British Isles Lupus Assessment Group index in pediatric clinical trials: comment on the article by Ruperto et alDavid Isenberg, Caroline Gordon
Nature Clinical Practice. Rheumatology|August 26, 2006
Systemic lupus erythematosus--2005 annus mirabilis?David Isenberg, Anisur Rahman
Expert Review of Clinical Immunology|May 15, 2015
Risk factors for renal disease in systemic lupus erythematosus and their clinical implicationsEleana Ntatsaki, David Isenberg
Rheumatology (Oxford, England)|May 7, 2010
Assessment of patients with primary Sjögren's syndrome--outcome over 10 years using the Sjögren's Syndrome Damage IndexLada Krylova, David Isenberg
Best Practice & Research. Clinical Rheumatology|July 14, 2009
Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapiesElsa Sousa, David Isenberg
The Journal of Rheumatology|October 6, 2005
Malignancy and rheumatic disease--a real association?Sharon Chambers, David Isenberg
Rheumatology (Oxford, England)|May 4, 2013
Effect of gender on clinical presentation in systemic lupus erythematosusGrainne Murphy, David Isenberg
Expert Opinion on Biological Therapy|October 21, 2020
Anti-IFNαR Mabs for the treatment of systemic lupus erythematosusBethan Goulden, David Isenberg
Presse Medicale (Paris, France : 1983)|May 6, 2014
Why and how should we measure disease activity and damage in lupus?Joy Feld, David Isenberg
Annals of the Rheumatic Diseases|July 6, 2013
Towards treating lupus nephritis without oral steroids: a dream-come-true?Frédéric A Houssiau, David Isenberg
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Arthritis and Rheumatism|June 28, 2006
Usefulness of the British Isles Lupus Assessment Group index in pediatric clinical trials: comment on the article by Ruperto et alDavid Isenberg, Caroline Gordon
Nature Clinical Practice. Rheumatology|August 26, 2006
Systemic lupus erythematosus--2005 annus mirabilis?David Isenberg, Anisur Rahman
Expert Review of Clinical Immunology|May 15, 2015
Risk factors for renal disease in systemic lupus erythematosus and their clinical implicationsEleana Ntatsaki, David Isenberg
Rheumatology (Oxford, England)|May 7, 2010
Assessment of patients with primary Sjögren's syndrome--outcome over 10 years using the Sjögren's Syndrome Damage IndexLada Krylova, David Isenberg
Best Practice & Research. Clinical Rheumatology|July 14, 2009
Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapiesElsa Sousa, David Isenberg
The Journal of Rheumatology|October 6, 2005
Malignancy and rheumatic disease--a real association?Sharon Chambers, David Isenberg
Rheumatology (Oxford, England)|May 4, 2013
Effect of gender on clinical presentation in systemic lupus erythematosusGrainne Murphy, David Isenberg
Expert Opinion on Biological Therapy|October 21, 2020
Anti-IFNαR Mabs for the treatment of systemic lupus erythematosusBethan Goulden, David Isenberg
Presse Medicale (Paris, France : 1983)|May 6, 2014
Why and how should we measure disease activity and damage in lupus?Joy Feld, David Isenberg
Annals of the Rheumatic Diseases|July 6, 2013
Towards treating lupus nephritis without oral steroids: a dream-come-true?Frédéric A Houssiau, David Isenberg
Pageof 19